Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Lygren

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|July 11, 2008
The potential use of AKAP18delta as a drug target in heart failure patientsBirgitte Lygren, Kjetil Taskén
Journal of Immunological Methods|September 24, 2005
A fast and sensitive method for isolation of detergent-resistant membranes from T cellsBirgitte Lygren, Kjetil Taskén, Cathrine R Carlson
The Biochemical Journal|September 1, 2009
Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signallingEirik A Torheim, Elisabeth Jarnaess, Birgitte Lygren, et al.
The Biochemical Journal|October 28, 2009
The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMPAnne Jorunn Stokka, Randi Mosenden, Anja Ruppelt, et al.
The Journal of Biological Chemistry|October 1, 2008
Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type IElisabeth Jarnaess, Anja Ruppelt, Anne Jorunn Stokka, et al.
Journal of Cell Science|July 24, 2014
A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusionGuillaume Pidoux, Pascale Gerbaud, Jim Dompierre, et al.
The Journal of Biological Chemistry|May 27, 2006
Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptorCathrine Rein Carlson, Birgitte Lygren, Torunn Berge, et al.
Biochemical and Biophysical Research Communications|February 7, 2012
Both El Tor and classical cholera toxin bind blood group determinantsJulie E Heggelund, Espen Haugen, Birgitte Lygren, et al.
Molecular Cell|November 4, 2006
Molecular basis of AKAP specificity for PKA regulatory subunitsMatthew G Gold, Birgitte Lygren, Pawel Dokurno, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 4, 2026
Signe Øien Fretland, Birgitte Lygren, Ravinder Singh, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|July 11, 2008
The potential use of AKAP18delta as a drug target in heart failure patientsBirgitte Lygren, Kjetil Taskén
Journal of Immunological Methods|September 24, 2005
A fast and sensitive method for isolation of detergent-resistant membranes from T cellsBirgitte Lygren, Kjetil Taskén, Cathrine R Carlson
The Biochemical Journal|September 1, 2009
Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signallingEirik A Torheim, Elisabeth Jarnaess, Birgitte Lygren, et al.
The Biochemical Journal|October 28, 2009
The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMPAnne Jorunn Stokka, Randi Mosenden, Anja Ruppelt, et al.
The Journal of Biological Chemistry|October 1, 2008
Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type IElisabeth Jarnaess, Anja Ruppelt, Anne Jorunn Stokka, et al.
Journal of Cell Science|July 24, 2014
A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusionGuillaume Pidoux, Pascale Gerbaud, Jim Dompierre, et al.
The Journal of Biological Chemistry|May 27, 2006
Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptorCathrine Rein Carlson, Birgitte Lygren, Torunn Berge, et al.
Biochemical and Biophysical Research Communications|February 7, 2012
Both El Tor and classical cholera toxin bind blood group determinantsJulie E Heggelund, Espen Haugen, Birgitte Lygren, et al.
Molecular Cell|November 4, 2006
Molecular basis of AKAP specificity for PKA regulatory subunitsMatthew G Gold, Birgitte Lygren, Pawel Dokurno, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 4, 2026
Signe Øien Fretland, Birgitte Lygren, Ravinder Singh, et al.
Pageof 2